Pluxee's Stock Rises 2% Despite Chilean Episode
The employee benefits specialist recovers part of its annual decline and moves back into weekly green. This movement comes as the SBF 120 significantly rises at midday, two sessions after the disclosure of a procedure by the Chilean competition authority targeting its local subsidiary.
Kepler Cheuvreux Maintains €18 Target Following Chilean Episode
On May 27, Kepler Cheuvreux reaffirmed its buy recommendation on Pluxee with an unchanged price target of €18, the same day the notification of a procedure opened by the Chilean National Economic Prosecutor's Office against the local subsidiary was announced. With the current price at €12.27, the broker's target theoretically offers a nearly 47% margin. According to the consensus of analysts surveyed, the stock is trading at about 8.3 times the earnings expected for the current fiscal year and 8.0 times those of the following year, with an estimated earnings per share growth of +3.4% from one year to the next. Kepler's recommendation follows that of Jefferies, which had raised its target in mid-May. Direct competitor Edenred is up 1.80% at the same time.
The Stock Crosses Its 50-Day Moving Average and Approaches Its Resistance at €12.52
The price at €12.27 moves above the 50-day moving average (€11.50), with a 6.7% gap that reflects the improvement in short-term dynamics. However, it remains below the 200-day moving average (€13.32), about 7.9% under this long-term benchmark, reminding that the overall trend remains weak after a loss of nearly 38% over the year. The identified resistance at €12.52 is within immediate reach, less than 2.5% from the current price, having already been tested in early May. The RSI at 53 remains neutral and sends no signal of excess.
